MoU to Facilitate Partnership in Healthcare-Related Research Projects as well as Internship and Work Placement offers for Khalifa University Students
Khalifa University of Science and Technology and Hayat Biotech, the UAE based biotechnology leader, announced the signing of a memorandum of understanding (MoU) to collaborate on research projects, human capital development, and career enhancement.
The MoU was signed by Professor Sir John O’Reilly, President, Khalifa University, and Naser Al Yammahi, Deputy Chief Executive Officer, Hayat Biotech, while senior officials from both partners were present at the ceremony that was organized on the sidelines of Arab Health 2023. The MoU will facilitate collaboration in healthcare-related research projects as well as internship and work placement offers for Khalifa University students.
Khalifa University’s research remains relevant nationally and internationally even as the top-ranked academic institution prioritizes creating skilled and proficient manpower suitably trained to lead the UAE’s fast-growing knowledge-economy companies both in the government and private sectors. The MoU is expected to pave the way for indigenous human capital that will prove its mettle not only in the region but also across the global community.
On signing the MoU, Naser Al Yammahi, Deputy Chief Executive Officer, Hayat Biotech, said, “At Hayat Biotech, we remain committed to the growth and development of the healthcare sector across the UAE through furthering medical education and research. The signing of this agreement with Khalifa University, a recognized and respected academic institution in the UAE, is testament to our unwavering commitment towards collaborating with renowned institutions from key sectors. We strongly believe that such collaborations contribute to the consistent enhancement and transformation of the UAE’s healthcare ecosystem.”
Mr. Al Yammahi added, “We are a homegrown company with global reach and a focused ambition, hence nurturing local talent is a key objective for Hayat Biotech. We seek to identify existing gaps and play a leading role in the development of the next generation of healthcare leaders and scientists. This stands to benefit not only the local community but also has positive implications on the regional and international healthcare industry.”
Commenting on the signing, Hongbin Cong, Chief Executive Officer, Hayat Biotech, said: “We are extremely proud to strengthen our collaboration with one of UAE’s most distinguished academic institutions, Khalifa University. Hayat Biotech is a firm believer in the power of collaboration to help build robust and sustainable research capabilities to benefit the world at large. Our ever-growing partnerships in key markets and sectors is an affirmation of our steadfast determination to becoming a leading international player while simultaneously fortifying our home-based operational efficiency and capabilities.”
“This MoU will focus on technologies and academia within the healthcare sector, to fully capitalize on the industry’s potential while fueling the advancement of research and medical education in the UAE. We pledge to forge ahead confidently as we lay the foundation to bring a positive impact on the wellbeing of the community.”
Clarence Michael
English Editor Specialist
2 February 2023
